Indian illegally occupied Jammu and Kashmir’s Drug and Food Control Organisation (DFCO) has imposed a ban on the sale, distribution, and use of three cough syrup brands, including ColdRif Syrup, RespiFresh-TR, and Relif Syrup, after laboratory tests declared them “Not of Standard Quality” due to the presence of toxic impurities.
The affected formulations include Relif Syrup manufactured by M/s Shape Pharma Pvt Ltd, Gujarat, and marketed by Leo Life Science Pvt Ltd, Ahmedabad; RespiFresh-TR Syrup manufactured by M/s Rednex Pharmaceuticals Ltd, Ahmedabad, and marketed by Smartway Wellness Pvt Ltd, Sanand; and ColdRif Syrup manufactured by M/s Sresan Pharmaceuticals, Tamil Nadu.
The DFCO notice said the drug formulations of cough syrups have been declared as “Not of Standard Quality” as they have failed to comply with the requirement of “Presence of Impurities of Diethylene Glycol is more than permissible limit” as per the Govt. Analyst, Drug Testing Laboratory, Food and Drug Administration, M.P.
The notice asked the Director of Soura hospital and all Principals of Medical College Hospitals in occupied Jammu and Kashmir to disseminate the information to all Heads of Departments (HoDs) for necessary action. Any stock available in the territory is to be brought to the notice of the office of the Drug Controller.
